
47.00 Delayed Data As of Feb 07 | ![]() Today’s Change | 36.91 Today|||52-Week Range 58.10 | -2.95% Year-to-Date |
New Strong Buy Stocks for February 7th Feb 07 / Zacks.com - Paid Partner Content | Sanofi (SNY) Q4 Earnings Miss Estimates, Vaccine Sales Weak Feb 03 / Zacks.com - Paid Partner Content |
Sanofi (SNY) Q4 2022 Earnings Call Transcript Feb 03 / MotleyFool.com - Paid Partner Content | Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits Feb 03 / Zacks.com - Paid Partner Content |
Gilead (GILD) Q4 Earnings & Sales Top on Biktarvy & Oncology Feb 03 / Zacks.com - Paid Partner Content | Bristol-Myers (BMY) Q4 Earnings Top, Revlimid Generic Impact Sales Feb 02 / Zacks.com - Paid Partner Content |
Chubb Ltd Buys 2, Sells 3 in 4th Quarter Feb 03 / GuruFocus News - Paid Partner Content | Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal Feb 02 / Zacks.com - Paid Partner Content |
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline Feb 03 / Zacks.com - Paid Partner Content | Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints Feb 02 / Zacks.com - Paid Partner Content |
Previous close | 45.86 |
Today’s open | 46.28 |
Day’s range | 46.21 - 47.06 |
Volume | 2,424,838 |
Average volume (3 months) | 2,719,824 |
Market cap | $115.3B |
Earnings growth (last year) | -- |
Earnings growth (this year) | +1.52% |
Earnings growth (next 5 years) | +7.50% |
Revenue growth (last year) | -- |
P/E ratio | 17.2 |
Price/Sales | 2.68 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
REGNRegeneron Pharmaceut... | -10.92 | -1.40% |
VRTXVertex Pharmaceutica... | +3.67 | +1.20% |
ZTSZoetis Inc | +0.64 | +0.39% |
---- |
Next reporting date | April 27, 2023 |
EPS forecast (this quarter) | $1.10 |
Annual revenue (last year) | -- |
Annual profit (last year) | -- |
Net profit margin | 15.63% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |